Ê×Ò³| Â鶹´«Ã½Ó³»­

UNLV and the Cleveland Clinic Lou Ruvo Center for Brain Health have received an $11.3 million federal grant for the next phase of their joint research into the causes of degenerative brain diseases such as Alzheimer’s and potential treatments.

More than 1100 people filled the Las Vegas Ballpark Saturday morning for the annual Alzheimer’s Association Walk to End Alzheimer’s.

BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that it will host a key opinion leader webinar on neuroinflammation and insulin resistance and new treatment approaches for Alzheimer’s Disease on Tuesday, October 26, 2021 at 1:30 pm Eastern Time.

UNLV is leading the way towards an eventual cure for Alzheimer’s with groundbreaking research.

Researchers at UNLV say they’ve strengthened the link between Type II diabetes and Alzheimer’s disease, which saps brain function and has no cure.

A team of neuroscientists from UNLV has confirmed the link between type 2 diabetes and Alzheimer's disease (AD) in a recent study published in the journal Communications Biology.

tudy shows chronic hyperglycemia impairs working memory performance and alters fundamental aspects of working memory brain networks. The findings strengthen the link between type 2 diabetes and Alzheimer’s disease.

Type 2 diabetes may up the risk for Alzheimer's disease by altering brain function, new animal research suggests.